Ghost Tree Capital as of June 30, 2021
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 51 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 11.2 | $41M | 300k | 135.40 | |
| Rapt Therapeutics (RAPT) | 5.0 | $18M | 570k | 31.79 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 4.9 | $18M | 135k | 131.55 | |
| Fate Therapeutics (FATE) | 4.4 | $16M | 185k | 86.79 | |
| Xenon Pharmaceuticals (XENE) | 4.4 | $16M | 850k | 18.62 | |
| Arvinas Ord (ARVN) | 4.3 | $16M | 205k | 77.00 | |
| Syndax Pharmaceuticals (SNDX) | 4.1 | $15M | 875k | 17.17 | |
| Kura Oncology (KURA) | 4.0 | $15M | 700k | 20.85 | |
| Cogent Biosciences (COGT) | 3.6 | $13M | 1.6M | 8.11 | |
| Trillium Therapeutics Com New | 3.3 | $12M | 1.3M | 9.70 | |
| Iovance Biotherapeutics (IOVA) | 3.2 | $12M | 450k | 26.02 | |
| Biogen Idec (BIIB) | 3.1 | $11M | 33k | 346.28 | |
| Celldex Therapeutics Com New (CLDX) | 2.6 | $9.5M | 285k | 33.44 | |
| Mirati Therapeutics | 2.2 | $8.1M | 50k | 161.54 | |
| Allogene Therapeutics (ALLO) | 2.0 | $7.2M | 275k | 26.08 | |
| Tg Therapeutics (TGTX) | 1.9 | $7.0M | 180k | 38.79 | |
| Aldeyra Therapeutics (ALDX) | 1.9 | $6.8M | 600k | 11.33 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.8 | $6.5M | 1.0M | 6.54 | |
| Miragen Therapeutics (VRDN) | 1.8 | $6.4M | 350k | 18.29 | |
| Satsuma Pharmaceuticals Ord | 1.8 | $6.4M | 904k | 7.05 | |
| Vistagen Therapeutics Com New | 1.7 | $6.3M | 2.0M | 3.15 | |
| Mersana Therapeutics (MRSN) | 1.7 | $6.1M | 450k | 13.58 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.7 | $6.1M | 200k | 30.36 | |
| Essa Pharma Com New (EPIX) | 1.6 | $5.9M | 208k | 28.57 | |
| Rocket Pharmaceuticals (RCKT) | 1.5 | $5.5M | 125k | 44.29 | |
| Helix Acquisition Corp Com Cl A | 1.4 | $5.2M | 500k | 10.35 | |
| Galapagos Nv Spon Adr (GLPG) | 1.4 | $5.2M | 75k | 68.89 | |
| Tarsus Pharmaceuticals (TARS) | 1.4 | $4.9M | 170k | 28.98 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.3 | $4.6M | 243k | 18.85 | |
| Iveric Bio | 1.3 | $4.6M | 725k | 6.31 | |
| Aclaris Therapeutics (ACRS) | 1.2 | $4.4M | 250k | 17.56 | |
| Catalyst Biosciences Com New | 1.2 | $4.3M | 1.0M | 4.33 | |
| Cti Biopharma | 1.1 | $4.0M | 1.6M | 2.50 | |
| Sierra Oncology Com New | 1.1 | $3.9M | 200k | 19.47 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.0 | $3.5M | 125k | 28.23 | |
| Vaxcyte (PCVX) | 0.9 | $3.3M | 145k | 22.51 | |
| Immunic (IMUX) | 0.9 | $3.2M | 265k | 12.26 | |
| Kadmon Hldgs | 0.9 | $3.1M | 800k | 3.87 | |
| Amicus Therapeutics (FOLD) | 0.7 | $2.6M | 265k | 9.64 | |
| Immunovant Call Option (IMVT) | 0.6 | $2.1M | 200k | 10.57 | |
| Provention Bio Put Option | 0.6 | $2.1M | 250k | 8.43 | |
| Curis Com New | 0.5 | $2.0M | 247k | 8.07 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.5 | $1.9M | 75k | 25.63 | |
| Chimerix (CMRX) | 0.4 | $1.6M | 200k | 8.00 | |
| Merus N V (MRUS) | 0.4 | $1.6M | 75k | 21.07 | |
| Elevation Oncology (ELEV) | 0.4 | $1.4M | 100k | 13.57 | |
| Casi Pharmaceuticalsinc Com Stk | 0.3 | $1.0M | 650k | 1.55 | |
| Otonomy | 0.3 | $1.0M | 450k | 2.23 | |
| Larimar Therapeutics (LRMR) | 0.3 | $982k | 100k | 9.82 | |
| Moderna (MRNA) | 0.3 | $940k | 4.0k | 235.00 | |
| Codex Dna (TBIO) | 0.2 | $770k | 35k | 22.00 |
